Try our mobile app

General information

MD Medical Group Investments PLC is a private healthcare provider in Russia. The Company specializes in women's and children's healthcare.
  • Good financial results growth rate 13.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (9.7%)
  • Dividend yield for the last twelve months 6.2%
  • Free cash flow yield 11.5% (LTM)
  • Share price is 200.6% higher than minimum and 13.8% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (6.8x vs
    )
  • Fundamental value created in LTM (estimate)
  • Taking into account the impact of the key rate 20.0% on the change in financial parameters: EBITDA adjustment is 471 mln rub as NetDebt * (current key rate - normalized 7%) / 2, expected EBITDA adjusted for key rate increases is 11 650 mln rub, expected mult is 6.0x, target mult is 5.1x, potential is -14.1%

Key Financials (Download financials)

Ticker: MDMG
Share price, RUB:  (0.0%)1031.2
year average price 924.57  


year start price 826.20 2024-07-03

min close price 799.00 2024-07-05

max close price 1130.00 2025-03-21

current price 1027.80 2025-07-02
Common stocks: 75 130 000

Dividend Yield:  6.2%
FCF Yield LTM: 11.5%
EV / LTM EBITDA:6.8x
EV / EBITDA annualized: 6.5x
Last revenue growth (y/y):  17.5%
Last growth of EBITDA (y/y):  9.8%
Historical revenue growth:  9.8%
Historical growth of EBITDA:  9.5%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
Fundamental value created in LTM:
 Mult Upside-21.2%
 FCF Creation+11.5%
 Growth+13.6%
 Growth Corr+2.0%
 
 Sum+5.8%
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 77 474
Net Debt (m RUB): -4 448
EV (Enterprise Value): 73 026
EBITDA LTM (m RUB): 10 681
Net Income LTM (m RUB): -4
EV / LTM EBITDA: 6.8x
Net Debt / LTM EBITDA (if EBITDA > 0): -0.4x
Average daily trading volume for the week, RUB mln: 39
P / B 2.5x
EBITDA margin ann-d 32.4%
Net income margin ann-d 0.0%

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

P/B and P/E multipliers

P / B

P / E

More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company